相关实验视频
Updated: May 30, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
核Farnesoid X受体通过稳定RUNX2驱动骨质母细胞分化来防止骨质损失
Qi Dong1,2, Haoyuan Fu1,2, Wenxiao Li1,2
1Department of Orthopedic Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
法尔内索伊德X受体 (FXR) 对于骨健康至关重要,促进骨质母细胞分化和骨发育. 用像Obeticol酸这样的激素准FXR显示出治疗骨质疏松症的前景.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 分子生物学分子生物学
背景情况:
- 骨质稳定依赖于平衡的骨质细胞和骨质细胞活动.
- 核受体 (NR) 显著影响骨生理学和病理学.
- 法尔内索伊德X受体 (FXR) 在骨调节中的作用尚未完全理解.
研究的目的:
- 为了研究FXR在骨质平衡中的功能.
- 阐明FXR调节骨质细胞分化的分子机制.
- 评估FXR激活剂在骨质疏松症中的治疗潜力.
主要方法:
- 在体外和体内研究中,在骨髓中介质干细胞 (BMSC) 和骨质母细胞中使用缺乏FXR的小鼠.
- 对骨质母细胞分化和骨发育的分析.
- 研究了FXR,RUNX2和Thoc6.6之间的相互作用.
- 在卵巢切除诱导的骨质疏松症模型中对OCA的评估.
主要成果:
- 在BMSC和骨质母细胞中失去FXR导致骨发育延迟和骨质疏松症表型.
- FXR通过抑制Thoc6介导的全方位化,通过稳定RUNX2促进骨质生成活性.
- 通过与其促进体结合,FXR直接抑制Thoc6的表达.
- 在卵巢切除诱导的骨质疏松症模型中,OCA治疗改善了骨损失.
结论:
- FXR是骨质母细胞分化和骨形成的关键调节者.
- FXR稳定了RUNX2,促进了骨质生成.
- 向FXR代表了对骨质疏松症的潜在治疗策略.
更多相关视频
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
相关概念视频
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
TGF - β Signaling Pathway
Regulation of Nuclear Protein Sorting